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Case report: a novel KERA mutation
associated with cornea plana and its
predicted effect on protein function
Laura Roos1*, Birgitte Bertelsen1, Pernille Harris2, Anette Bygum3, Hanne Jensen4, Karen Grønskov1
and Zeynep Tümer1
Abstract
Background: Cornea plana (CNA) is a hereditary congenital abnormality of the cornea characterized by reduced
corneal curvature, extreme hypermetropia, corneal clouding and hazy corneal limbus. The recessive form, CNA2, is
associated with homozygous or compound heterozygous mutations of the keratocan gene (KERA) on chromosome
12q22. To date, only nine different disease-associated KERA mutations, including four missense mutations, have
been described.
Case presentation: In this report, we present clinical data from a Turkish family with autosomal recessive cornea
plana. In some of the affected individuals, hypotrichosis was found. KERA was screened for mutations using Sanger
sequencing. We detected a novel KERA variant, p.(Ile225Thr), that segregates with the disease in the homozygous
form. The three-dimensional structure of keratocan protein was modelled, and we showed that this missense
variation is predicted to destabilize the structure of keratocan, leading to the classical ocular phenotype in the
affected individuals. All the four known missense mutations, including the variation found in this family, affect the
conserved residues of the leucine rich repeat domain of keratocan. These mutations are predicted to result in
destabilization of the protein.
Conclusion: We present the 10th pathogenic KERA mutation identified so far. Protein modelling is a useful tool in
predicting the effect of missense mutations. This case underline the importance of the leucin rich repeat domain
for the protein function, and this knowledge will ease the interpretation of future findings of mutations in these
areas in other families with cornea plana.
Keywords: Cornea plana 2, Hypotrichosis, KERA protein, Missense mutation, Protein modelling, Leucin rich repeat
domain
Background
Cornea plana is a rare hereditary congenital abnormality
of the cornea characterized by reduced corneal curva-
ture, extreme hypermetropia, corneal clouding and hazy
corneal limbus. There is an autosomal dominant (CNA1;
OMIM 121400) and a more severe autosomal recessive
form (CNA2; OMIM 217300) of the disorder. The reces-
sive form is more frequently associated with additional
ocular manifestations, such as iris malformation and
adhesions between cornea and iris [1–4]. The gene de-
fective in CNA1 has not been identified yet, while
homozygous or compound heterozygous mutations in
the keratocan gene (KERA) on chromosome 12q22 are
shown to cause CNA2 [5]. The protein encoded by
KERA, keratocan, is a keratan sulfate proteoglycan with
a core of leucine-rich repeats (LRR), flanked by clusters
of cystein, essential to maintain the three-dimensional
structure of the protein. Keratocan is an extracellular
matrix molecule of the corneal stroma that is important
for normal cornea morphogenesis and involved in main-
taining corneal transparency [6]. Studies with mice show
expression of this gene during eye development and in
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adult mice, it is exclusively expressed in the cornea
[7]. To date, only nine different disease-associated
KERA mutations have been reported in various popu-
lations [5, 8–11]: Three nonsense mutations, four mis-
sense mutations, one splice-site mutation, and one
frameshift (single-nucleotide deletion) mutation. All
the reported missense mutations are within the LRR
domain, which is considered to be essential for the
binding between keratocan and the collagen fibrils in
the corneal matrix during development. A disruption
of the protein affects both the structure and the trans-
parency of the cornea [12].
In this report, we present the clinical data and de-
scribe a new KERA mutation in a Turkish family with
autosomal recessive cornea plana. We suggest the gen-
etic variation to result in destabilization of the protein
structure. We furthermore apply protein modelling to
predict the effect of the missense mutations on the
structure of keratocan.
Case presentation
Clinical studies
A pedigree of the family is shown in Fig. 1a. The index
individuals (IV:4 and IV:5) are dizygotic male twins, who
were 11 years old at the time of clinical examination.
They were born at gestational age 36 to healthy and un-
related parents. Birth weights were 2300 g (IV:4) and
2352 g (IV:5). Shortly after birth, IV:4 and IV:5 were
found to be excessive hypermetropic (+11,75D/+11,75D
and 12,75D/+13,75D) and both had corneal clouding
and flat corneas. The boys have been wearing glasses
since the age of 3 months, and have been monitored fre-
quently. The clouding of the corneas decreased over the
first 8 months of life. Clinical and eye examinations were
carried out at the age of 10 years showing hazy corneal
limbi with vessels were noticed (Fig. 1c). IV:4 has a small
temporal iridocorneal synechi. Axial lengths were within
normal range (A-scan using Hiscan opticon). ERG, mo-
tility, pupillary reaction, funduscopy and intraocular
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Fig. 1 Family with cornea plana. a. The pedigree is consistent with autosomal recessive inheritance; b. The right eye of patient IV:3, with a small,
malformed pupil, and a hazy corneal limbus; c. The eyes of patient IV:4; d. The scalp of patient IV:4 at age 11, showing hypotrichosis on the
anterior part of vertex
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pressure were normal. Keratometry (Zeiss keratometer)
showed bilateral flat corneas and high astigmatism in
both boys (Additional file 1: Table S1).
The boys’ general development has been in the lower
range of normal. They attend a normal school at normal
age level, but perform in the low end of their class. They
both have slight behavioural problems and motor tics,
which are also found in their unaffected younger
brother. From the age of 9 years IV:4 has experienced
progressive frontal hair loss on vertex, the hair being
lighter in colour and lusterless (Fig. 1d). Hair micros-
copy was normal without any signs of hair shaft dis-
order. IV:5 has slight general hypermobility and pes
planus.
Family history
There were several affected individuals in the family, and
the pedigree was suggestive of autosomal recessive in-
heritance (Fig. 1a). Clinical information of the individ-
uals III:10, III:11, IV:3, IV:9, V:1 and V:2 was extracted
from charts of previous examinations. For individuals
III:12, IV:1, IV:2 and IV:8 clinical information was ob-
tained from family members. Clinical details on family
members are found in Table 1, Fig. 1b and Additional
file 1: Table S1.
Molecular studies
The clinical features and family history prompted us to
sequence KERA. Genomic DNA was isolated from per-
ipheral blood lymphocytes using Chemagnic Magnetic
Separation Modile 1 (Chemagen, Baesweiler, Germany).
Coding exons (exon 2 and 3) of KERA were amplified
from genomic DNA of the investigated family members
using PCR. Purified PCR products were sequenced using
BigDye Terminator v3.1 Cycle Sequencing Kit (Applied
Biosystems, Foster City, CA). Sequencing products were
purified and run on an ABI 3130 XL genetic analyzer
(AppliedBiosystems). Sequences of the coding exons and
10 bp of the flanking introns were analyzed using SeqS-
cape software (AppliedBiosystems). Primer sequences
and PCR conditions are available on request.
A novel missense mutation was detected in exon 2 of
KERA, c.674T>C, which is predicted to result in sub-
stitution of isoleucine at position 225 with threonine,
p.(Ile225Thr). All affected family members investigated
for the mutation (IV:3, IV:4 and IV:5) were homozygous,
while the clinically unaffected parents (III: 3 and III:4),
the brother (IV:6), a maternal aunt (III:7) and a maternal
uncle (III:5) were all heterozygous for the mutation. .
The mutation is absent from the 1000 Human Genome
[13] and NHLBI Exome Sequencing [14] databases. The
Ile225 lies within the LRR domain and is a highly con-
served amino acid. The in silico prediction programs
SIFT [15] and Polyphen2 [16] predict the substitution to
be pathogenic (SIFT score 0.00 and Polyphen2 score
0.999).
Protein modelling
We modelled the three-dimensional structure of the
keratocan protein to predict the effect of the present
mutation and the three previously published missense
mutations on protein structure/function.
The LRR protein core of decorin (PDB entry 1xku_A)
[17] was used as template. The template was chosen
using BLASTp[18] to search against the protein data
bank. ClustalW [19] was used to align the two sequences
and SWISS-MODEL [20] was used to change the amino
acids. Finally, the structure was investigated using Pymol
Table 1 Clinical features of the affected individuals
Individual Present age
(years)
Cornea
plana
Hazy corneal
limbus
Irido-corneal
synechi
Other eye abnormalities Other systemic abnormalities
III:10 40 Yes Yes No Corneal clouding has not decreased. Central
corneal thinning, suspicion of posterior lenticonus
Hair loss in early adulthood
III:11 39 Yes Yes No Corneal clouding decreased within the first year.
Slight lenticonus
Hair loss in early adulthood
IV:3 22 Yes Yes Yes Corneal clouding decreased within the first year.
Small, eccentric malformed pupil (right) (Fig. 2a)
None
IV:4 11 Yes Yes Yes Corneal clouding decreased within the first year. Hair loss. Motor tics. Slight
learning disability
IV:5 11 Yes Yes No Corneal clouding decreased within the first year. Slight learning disability. Soft
cartilage, hypermobility. Motor
tics
IV:9 35 Yes No No Corneal clouding, anterior pole cataract, remnants
of pupillary membrane
None
V:1 6 Yes Yes No Corneal clouding decreased within the first year.
Ectopia of pupils, left pupil irregular
None
V:2 7 Yes No Yes Slight corneal clouding, decreased within the first
year. Small, malformed and ectopic pupil (left)
None
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[21]. The number of LRR repeats were predicted using
LRRfinder [22]. Keratocan has a LRR structure, where the
leucine rich motif is repeated several times. It has the
shape of a curved solenoid, where the concave side of the
structure is made up of a parallel beta-sheet and the con-
vex side is made up of a more diverse number of struc-
tural elements (Fig. 2d and e). The leucine-rich motif
LXXLXLXXNXL at the concave side of the tandem is
highly conserved: The L may be leucine or a hydrophobic
amino acid, N may be asparagine or cysteine, and X may
be any amino acid (Fig. 2c). The interior of the LRR do-
main is made up of hydrophobic residues – with the ex-
ception of the conserved asparagines (Asn, N) which
create an Asn-ladder stabilizing the structure as seen in
Fig. 2e [23–25]. Previously, 10 LRR repeats were suggested
for keratocan [5], but the LRRfinder [22] suggests pres-
ence of an 11th LRR repeat starting at amino acid position
322 (Fig. 2c).
We found that the p.(Asn131Asp) and p.(Asn247Ser)
mutations affect the conserved Asn131 and Asn247 resi-
dues of the 3rd and 7th LRR-repeat. The substitution of
an Asn with an Aspartic acid or a Serine will change a
hydrogen bond donor to a hydrogen bond acceptor or to
neutral. The important stabilizing structure of the Asn-
ladder, which is seen in Fig. 2e, is likely to be destroyed.
The p.(Thr215Lys) mutation affects the Thr215 in the
beginning of the 7th repeat where the threonine is point-
ing into the structure. Substitution of this residue with ly-
sine is likely to destroy the structure in this area due to
steric hindrance of the large lysine side chain.
The p.(Ile107Arg) and the current mutation,
p.(Ile225Thr) affects the 11th residue within the 2nd and
the 7th repeat (the end of the beta-strain) where the iso-
leucine is pointing into the structure, stabilizing the
hydrophobic core. Substitution of the hydrophobic isoleu-
cine with the hydrophilic and bulky arginine or the
Fig. 2 The KERA mutations associated with cornea plana. a. Schematic representation of the KERA gene and b. the predicted protein, including
the positions of the disease causing mutations identified until now. The p.(Ile225Thr) missense mutation, identified in this study, changes an
isoleucine (Ile, I) to a threonine (Thr, T) at amino acid position 225 (shown in bold). Seven out of nine mutations, including the p.(Ile225Thr)
mutation, are predicted to affect the leucine-rich repeat region, LRR. c. Alignment of the leucine rich repeat domains show the 11 consensus
motifs LXXLXLXXNXL (shaded with gray) and the positions of the five missense mutations p.(Ile107Arg), p.(Asn131Asp), p.(Thr215Lys), p.(Ile225Thr)
and p.(Asn247Ser) that are underlined (I,N, T, I, and N, respectively). d. The transverse section of the protein model through the solenoid has been
made around the 7th repeat and amino acids Thr215 (T215), Ile225 (I225) and Asn247 (N247) is indicated. The mutations leading to substitution
of these aminoacids are shown in 2B. e. A side view of the structure shows the hydrogen bonding network of the asparagines which form the
Asn-ladder. The structure is made from homology modelling and the side chain rotamers may be different in the human protein. The dotted lines
show the hydrogen bonds
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hydrophilic threonine will most likely destabilize the
structure. It is interesting that the two mutations
p.(Ile107Arg) and p.(Asn131Asp) have the same special
orientation with respect to each other as the two muta-
tions p.(Ile225Thr) and p.(Asn247Ser).
Discussion
This family, with a novel missense mutation KERA
[p.(Ile225Thr)], exhibits the classical ocular phenotype
of autosomal recessive cornea plana, with excessive
hypermetropia, hazy corneal limbus, and (although vari-
able) iris malformation and iridocorneal adhesions.
Only nine different disease-associated mutations have
been previously reported in KERA [4;5;8–11] (Fig. 2a, b,
c). There are several lines of evidence suggesting that
p.(Ile225Thr) is causative: The mutation segregates with
the disease in the family and it affects a conserved resi-
due located within the LRR domain which is predicted
to be important for protein function. In silico analysis
predicts the mutation to be damaging and protein mod-
elling suggests that substitution of isoleucine at position
225 of the 7th LRR repeat will result in destabilization of
the protein structure. We therefore consider this muta-
tion the most likely cause of cornea plana in this family.
Three affected family members were homozygous for
the mutation. The parents of patient IV:3 are consan-
guineous. The parents of the index patients IV:4 and
IV:5 are not, to their own knowledge, consanguineous,
but descend from the same area. Since they are both
heterozygous for the same mutation, we speculate that
they are distantly related. If the mutation is found in
other Turkish families, however, a founder effect could
be considered.
Several family members have sparse scalp hair, and
one of the twins exhibits severe frontal hypotrichosis.
Although keratocan has not been linked to abnormalities
of the hair, another protein member of the small LRR
proteoglycan family, called Tsukushi (TSK), is found to
be expressed at the restricted areas of hair follicles dur-
ing the morphogenesis, and targeted disruption of TSK
causes the hair cycle to be delayed in mice [17]. How-
ever, the expression pattern of keratocan in the hair fol-
licle has not been examined. Hair loss has not previously
been described in connection with cornea plana. Pedi-
gree analysis does not show a clear connection between
hair loss and the mutation - family members not homo-
zygous for the mutation also show some thinning of the
hair, which might be androgenetic. If more cases of hair
loss in cornea plana patients emerge, expression studies
of keratocan in the hair follicle should be considered.
Conclusions
KERA mutations are very rare and we present the 10th
pathogenic mutation identified so far. Protein modelling
is a useful tool in predicting the effect of missense muta-
tions. Our studies suggest that the five amino acid sub-
stitutions associated with cornea plana are likely to
exercise their effect by destabilizing the structure of the
keratocan protein, underlining the importance of this
domain for the protein function. This is valuable know-
ledge when interpreting the clinical significance of future
KERA mutations.
Consent
The project conformed to the tenets of the Declaration
of Helsinki and was approved by the Regional Scientific
Ethical Committee for Copenhagen, Denmark. Written
informed consent was obtained from the patient for
publication of this Case report and any accompanying
images. A copy of the written consent is available for re-
view by the Series Editor of this journal.
Additional file
Additional file 1: Table S1. Best corrected visual acuity, biometric
characteristics and refractive error of affected family members.
Topography of patient IV:4.
Competing interests
The authors declare that they have no competing interests.
Authors’ contributions
LR conceived of the study, performed clinical examination of the patients
and drafted the manuscript. HJ performed eye examination on the patients.
AB performed dermatological examination and hair microscopy of the
patients. BB carried out the molecular genetic studies, and helped to draft
the manuscript. PH modelled and analysed the protein structure. ZT and KG
participated in the design of the study, and helped to draft the manuscript.
All authors read and approved the final manuscript.
Acknowledgements
We would like to thank the family for their participation in this study. BB is
currently supported by a scholarship from the University of Copenhagen.
Author details
1Applied Human Molecular Genetics, Kennedy Center, Copenhagen
University Hospital, Rigshospitalet, Gl. Landevej 7, Glostrup 2600, Denmark.
2Department of Chemistry, Technical University of Denmark, Kemitorvet
Build. 207, DK-2800 Kgs. Lyngby, Denmark. 3Department of Dermatology,
Odense University Hospital, Odense, Denmark. 4Eye Clinic, Department of
Ophthalmology, Copenhagen University Hospital, Glostrup, Denmark.
Received: 26 July 2014 Accepted: 15 May 2015
References
1. Khan AO, Aldahmesh M, Meyer B. Corneal ectasia and hydrops in a patient
with autosomal recessive cornea plana. Ophthalmic Genet. 2006;27(3):99–101.
2. Khan AO, Aldahmesh MA, Al-Gehedan S, Meyer BF, Alkuraya FS. Corneal
decompensation in recessive cornea plana. Ophthalmic Genet.
2009;30(3):142–5.
3. Tahvanainen E, Forsius H, Kolehmainen J, Damsten M, Fellman J, de la
Chapelle A. The genetics of cornea plana congenita. J Med Genet.
1996;33(2):116–9.
4. Khan AO, Aldahmesh M, Meyer B. Recessive cornea plana in the Kingdom
of Saudi Arabia. Ophthalmology. 2006;113(10):1773–178.
Roos et al. BMC Medical Genetics  (2015) 16:40 Page 5 of 6
5. Pellegata NS, Dieguez-Lucena JL, Joensuu T, Lau S, Montgomery KT, Krahe
R, et al. Mutations in KERA, encoding keratocan, cause cornea plana. Nat
Genet. 2000;25(1):91–5.
6. Tasheva ES, Funderburgh JL, Funderburgh ML, Corpuz LM, Conrad GW.
Structure and sequence of the gene encoding human keratocan. DNA Seq.
1999;10(1):67–74.
7. Liu CY, Shiraishi A, Kao CW, Converse RL, Funderburgh JL, Corpuz LM, et al.
The cloning of mouse keratocan cDNA and genomic DNA and the
characterization of its expression during eye development. J Biol Chem.
1998;273(35):22584–8.
8. Ebenezer ND, Patel CB, Hariprasad SM, Chen LL, Patel RJ, Hardcastle AJ,
et al. Clinical and molecular characterization of a family with autosomal
recessive cornea plana. Arch Ophthalmol. 2005;123(9):1248–53.
9. Khan A, Al-Saif A, Kambouris M. A novel KERA mutation associated with
autosomal recessive cornea plana. Ophthalmic Genet. 2004;25(2):147–52.
10. Liskova P, Hysi PG, Williams D, Ainsworth JR, Shah S, de la Chapelle A, et al.
Study of p.N247S KERA mutation in a British family with cornea plana. Mol
Vis. 2007;13:1339–47.
11. Dudakova L, Palos M, Hardcastle AJ, Liskova P. Corneal endothelial findings
in a Czech patient with compound heterozygous mutations in KERA.
Ophthalmic Genet. 2014;35(4):252–4.
12. Hassell JR, Birk DE. The molecular basis of corneal transparency. Exp Eye Res.
2010;91(3):326–35.
13. 1000 Genomes Project Consortium, Abecasis GR, Auton A, Brooks LD,
Depristo MA, Durbin RM, et al. An integreated map of genetic variation
from 1,092 human genomes. Nature. 2012;491(7422):56–65.
14. Tennessen JA, Bigham AW, O’connor TD, Fu W, Kenny EE, Gravel S, et al.
Evolution and functional impact of rare coding variation from deep
sequencing of human exomes. Science. 2010;337(6090):64–9.
15. Ng PC, Henikoff S. Predicting deleterious amino acid substitutions. Genome
Res. 2001;11(5):863–74.
16. Adzhubei IA, Schmidt S, Peshkin L, Ramensky VE, Gerasimova A, Bork P,
et al. A method and server for predicting damaging missense mutations.
Nat Methods. 2010;7(4):248–9.
17. Scott PG, McEwan PA, Dodd CM, Bergmann EM, Bishop PN, Bella J. Crystal
structure of the dimeric protein core of decorin, the archetypal small
leucine-rich repeat proteoglycan. Proc Natl Acad Sci U S A.
2004;101(44):15633–8.
18. Altschul SF, Madden TL, Schaffer AA, Zhang J, Zhang Z, Miller W, et al.
Gapped BLAST and PSI-BLAST: a new generation of protein database search
programs. Nucleic Acids Res. 1997;1;25(17):3389–402.
19. Larkin MA, Blackshields G, Brown NP, Chenna R, McGettigan PA, McWilliam
H, et al. Clustal W and Clustal X version 2.0. Bioinformatics.
2007;23(21):2947–8.
20. Arnold K, Bordoli L, Kopp J, Schwede T. The SWISS-MODEL workspace: a
web-based environment for protein structure homology modelling.
Bioinformatics. 2006;15;22(2):195–201.
21. The PyMOL Molecular Graphics System [computer program]. Version
Version 1.5.0.4 Schrödinger, New York, USA: LLC; 2014.
22. Offord V, Coffey TJ, Werling D. LRRfinder: a web application for the
identification of leucine-rich repeats and an integrative Toll-like receptor
database. Dev Comp Immunol. 2010;34(10):1035–41.
23. Bella J, Hindle KL, McEwan PA, Lovell SC. The leucine-rich repeat structure.
Cell Mol Life Sci. 2008;65(15):2307–33.
24. Kobe B, Deisenhofer J. The leucine-rich repeat: a versatile binding motif.
Trends Biochem Sci. 1994;19(10):415–21.
25. Kobe B, Deisenhofer J. Proteins with leucine-rich repeats. Curr Opin Struct
Biol. 1995;5(3):409–16.
Submit your next manuscript to BioMed Central
and take full advantage of: 
• Convenient online submission
• Thorough peer review
• No space constraints or color ﬁgure charges
• Immediate publication on acceptance
• Inclusion in PubMed, CAS, Scopus and Google Scholar
• Research which is freely available for redistribution
Submit your manuscript at 
www.biomedcentral.com/submit
Roos et al. BMC Medical Genetics  (2015) 16:40 Page 6 of 6
